0001127602-22-008047.txt : 20220303
0001127602-22-008047.hdr.sgml : 20220303
20220303170441
ACCESSION NUMBER: 0001127602-22-008047
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220301
FILED AS OF DATE: 20220303
DATE AS OF CHANGE: 20220303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jones Michael L
CENTRAL INDEX KEY: 0001800060
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 22710078
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BLVD.
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-859-1302
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-03-01
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001800060
Jones Michael L
4505 EMPEROR BLVD.
SUITE 200
DURHAM
NC
27703
1
Exec. Director, Finance - PAO
Common Stock
2022-03-01
4
M
0
2300
4.73
A
13498
D
Common Stock
2022-03-01
4
S
0
2300
17.20
D
11198
D
Emp. Stock Option (Right to Buy)
4.73
2022-03-01
4
M
0
2300
0
D
2013-03-01
2022-03-01
Common Stock
2300
0
D
Michael L. Jones
2022-03-03